Literature DB >> 21857845

Clinical and prognostic features of patients with pandemic 2009 influenza A (H1N1) virus in the intensive care unit.

B Sertogullarindan1, B Ozbay, H Gunini, A Sunnetcioglu, A Arisoy, H M Bilgin, B Mermit Cilingir, M Duran, H Yildiz, S Ekin, Ai Baran.   

Abstract

OBJECTIVE: To investigate the clinical and prognostic features of patients admitted to intensive care unit (ICU) with pandemic 2009 influenza A (H1N1) virus.
METHODS: Patients admitted to the intensive care unit for severe pneumonia associated with pandemic 2009 influenza A (H1N1) virus were evaluated.
RESULTS: The study included 20 patients with the mean age of 36±13. Of the 20 subjects, 17 (85%) had underlying conditions. Of the 20 patients, 11(55%) were discharged and 9 (45%) died. Cardinal symptoms were fever, myalgia, and hemoptysis with the rates of 85 %, 75 % and 45 %, respectively. All patients had pneumonic infiltrations in their chest roentgenograms. Main laboratory findings were lymphopenia, high creatin phosphokinase (CPK) and Lactate dehydrogenase (LDH) levels. All patients had positivity on real time reverse transcription-polymerase chain reaction (RT-PCR). None of the patients had pandemic 2009 influenza A (H1N1) virus vaccination. None of them had taken oseltamivir within 48 hours. Main reasons for mortality were cardiovascular complications and ventilatory associated pneumonia due to Acynetobacter baumannii.
CONCLUSION: Early diagnosis and antiviral treatment in these cases seem to be the best approach to avoid serious illness. Special attention should be given to patients having underlying conditions such as cardiovascular and pulmonary diseases and pregnancy.

Entities:  

Keywords:  Pandemic 2009 influenza A (H1N1); intensive care unit; prognosis

Mesh:

Substances:

Year:  2011        PMID: 21857845      PMCID: PMC3158518     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  26 in total

1.  Mortality from Influenza A/H1N1 in a tertiary care teaching institution in North India.

Authors:  Vishal Sharma; Pushpendra Kumar Verma; Sushan Gupta; Alka Sharma
Journal:  J Infect Dev Ctries       Date:  2010-09-03       Impact factor: 0.968

2.  Estimated cumulative incidence of pandemic (H1N1) influenza among pregnant women during the first wave of the 2009 pandemic.

Authors:  Salaheddin M Mahmud; Marissa Becker; Yoav Keynan; Lawrence Elliott; Laura H Thompson; Keith Fowke; Lisa Avery; Paul Van Caeseele; Sande Harlos; James Blanchard; Magdy Dawood
Journal:  CMAJ       Date:  2010-09-07       Impact factor: 8.262

3.  Pulmonary complications of interpandemic influenza A in hospitalized adults.

Authors:  Yoshihiko Murata; Edward E Walsh; Ann R Falsey
Journal:  J Infect Dis       Date:  2007-02-15       Impact factor: 5.226

4.  Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico.

Authors:  Rogelio Perez-Padilla; Daniela de la Rosa-Zamboni; Samuel Ponce de Leon; Mauricio Hernandez; Francisco Quiñones-Falconi; Edgar Bautista; Alejandra Ramirez-Venegas; Jorge Rojas-Serrano; Christopher E Ormsby; Ariel Corrales; Anjarath Higuera; Edgar Mondragon; Jose Angel Cordova-Villalobos
Journal:  N Engl J Med       Date:  2009-06-29       Impact factor: 91.245

5.  Influenza A/H1N1 (2009) infection in pregnancy--an Asian perspective.

Authors:  M L Lim; C Y Chong; W S N Tee; W Y Lim; J J Chee
Journal:  BJOG       Date:  2010-02-10       Impact factor: 6.531

6.  Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-10-02       Impact factor: 17.586

7.  Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan.

Authors:  Taro Kamigaki; Hitoshi Oshitani
Journal:  PLoS Curr       Date:  2009-12-20

8.  Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection.

Authors:  Ronan J Murray; James O Robinson; Jodi N White; Frank Hughes; Geoffrey W Coombs; Julie C Pearson; Hui-Leen Tan; Glenys Chidlow; Simon Williams; Keryn J Christiansen; David W Smith
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

9.  Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San Luis Potosí, Mexico.

Authors:  Alejandro Gómez-Gómez; Martin Magaña-Aquino; Christian Garcia-Sepúlveda; Uciel R Ochoa-Pérez; Reynaldo Falcón-Escobedo; Andreu Comas-García; Saray Aranda-Romo; Hugo I Contreras-Treviño; Paulina V Jimenéz-Rico; Mario A Banda-Barbosa; Félix Dominguez-Paulin; J Mario Bernal-Blanco; Luis F Peréz-González; Daniel E Noyola
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

10.  Deaths from bacterial pneumonia during 1918-19 influenza pandemic.

Authors:  John F Brundage; G Dennis Shanks
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more
  13 in total

Review 1.  Global burden of influenza as a cause of cardiopulmonary morbidity and mortality.

Authors:  William A Fischer; Michelle Gong; Satish Bhagwanjee; Jonathan Sevransky
Journal:  Glob Heart       Date:  2014-10-31

2.  Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Zhikang Ye; Ying Wang; Luis Enrique Colunga-Lozano; Manya Prasad; Wimonchat Tangamornsuksan; Bram Rochwerg; Liang Yao; Shahrzad Motaghi; Rachel J Couban; Maryam Ghadimi; Malgorzata M Bala; Huda Gomaa; Fang Fang; Yingqi Xiao; Gordon H Guyatt
Journal:  CMAJ       Date:  2020-05-14       Impact factor: 8.262

3.  A 30-year-old pregnant patient with massive haemoptysis and influenza A: Atypical presentation of a common pathogen.

Authors:  Philippe Nguyen; Florence Weber; Michèle Mahone
Journal:  Obstet Med       Date:  2013-07-11

4. 

Authors:  Zhikang Ye; Ying Wang; Luis Enrique Colunga-Lozano; Manya Prasad; Wimonchat Tangamornsuksan; Bram Rochwerg; Liang Yao; Shahrzad Motaghi; Rachel J Couban; Maryam Ghadimi; Malgorzata M Bala; Huda Gomaa; Fang Fang; Yingqi Xiao; Gordon H Guyatt
Journal:  CMAJ       Date:  2020-11-23       Impact factor: 8.262

5.  H1N1-infected Patients in ICU and Their Clinical Outcome.

Authors:  Talkad Chandrashekar Nagesh Kumar; Nanjangudu Subramanya Shivakumar; Telugu Sitaram Deepak; Rashmi Krishnappa; Melur Shivakumar Goutam; Vivek Ganigar
Journal:  N Am J Med Sci       Date:  2012-09

6.  Corticosteroids as adjunctive therapy in the treatment of influenza.

Authors:  Louise Lansbury; Chamira Rodrigo; Jo Leonardi-Bee; Jonathan Nguyen-Van-Tam; Wei Shen Lim
Journal:  Cochrane Database Syst Rev       Date:  2019-02-24

7.  Aging augments the impact of influenza respiratory tract infection on mobility impairments, muscle-localized inflammation, and muscle atrophy.

Authors:  Jenna M Bartley; Sarah J Pan; Spencer R Keilich; Jacob W Hopkins; Iman M Al-Naggar; George A Kuchel; Laura Haynes
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

8.  Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia.

Authors:  Hui Li; Shi-Gui Yang; Li Gu; Yao Zhang; Xi-Xin Yan; Zong-An Liang; Wei Zhang; Hong-Yu Jia; Wei Chen; Meng Liu; Kai-Jiang Yu; Chun-Xue Xue; Ke Hu; Qi Zou; Lan-Juan Li; Bin Cao; Chen Wang
Journal:  Influenza Other Respir Viruses       Date:  2017-06-09       Impact factor: 4.380

9.  Increased risk of refractory Mycoplasma pneumoniae pneumonia in children with atopic sensitization and asthma.

Authors:  Jeong Eun Shin; Bo Ram Cheon; Jae Won Shim; Deok Soo Kim; Hae Lim Jung; Moon Soo Park; Jung Yeon Shim
Journal:  Korean J Pediatr       Date:  2014-06-30

10.  Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis.

Authors:  Yi Zhang; Wenjie Sun; Erik R Svendsen; Song Tang; Raina C MacIntyre; Peng Yang; Daitao Zhang; Quanyi Wang
Journal:  Crit Care       Date:  2015-02-20       Impact factor: 19.334

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.